Search

Vita Nelson’s The Moneypaper specializes in direct investing through dividend-reinvestment plans, or DRIPs. However, this month Nelson also provided subscribers with some helpful advice for investing in fixed-income instruments in today’s low-yield environment, and explained the pros and cons of various types of bond funds. “Federal Reserve Chairman Bernanke has promised...

The White House has recently published an Executive Order intended to permit alternative asset investment, including real estate, commodities and private equity, in retirement accounts and 401(k)s. This month, let’s take a closer look at private equity. We’ll explore how it works, how it performs relative to public investments you’re no doubt already familiar with, how you can add private equity exposure right now, and, most importantly, whether you should.

Our portfolio has been largely treading water for a few weeks. That’s not surprising given that we’ve been waiting for earnings season to start (it finally has!) and that there’s this persistent sense that bad news for the economy resulting from the coronavirus equal more stimulus and accommodative fiscal policy equals support for equity markets and, in some ways, good news for certain tech and MedTech companies.

In my January 9 Cabot Wealth Advisory, I wrote about the three top performers of 2015. Today, I take a look at the next nine top performers like NeoPhotonics (NPTN), 5 Intra-Cellular Therapies (ITCI) and others.

Here are five ways you can lose big money quickly in growth stocks.

Many companies became extinct in the 1930s, but the companies that survived helped to build the U.S. into the greatest industrial nation to date. It is surprising how many of our current U.S. companies were founded more than 150 years ago.

Outsourcing can be a political hot button, as companies register complaints about sending jobs overseas and consumers gripe about incompatible language problems when they seek technological help. But like it or hate it, the truth is that outsourcing has saved American companies billions of dollars in labor costs, and it...

This week is the start of earnings season. We review Wells Fargo’s (WFC) earnings and provide updates on several Cabot Turnaround Letter recommended stocks.

Rising Treasury yields and geopolitical risks raise the prospect of uncertainty in the market. These conservative dividend stocks can help you weather the storm.

Dividend increases are often evidence of a company with cash to burn. Here are three stocks with rising dividends - and potentially share prices.

The recent market selloff has been intense, which means there are probably oversold gems out there, and these three stocks look like the best to buy on the dip.

Real estate investment trusts are special-purpose entities, with special tax status, that own real estate and pass along most of the income from the real estate (rents or mortgage payments) to shareholders. They can own any type of real estate, and many specialize in one type.

Five of the largest mega-cap stocks have a combined weight that accounts for nearly a quarter of the S&P 500. And right now, they’re saving the market.

A surge in new investors on the Robinhood trading application isn’t what’s driving this rally. But it could signal a Robinhood top is near.

With the stock market regularly surging to record highs, it may seem like an unusual time to focus on valuation. After all, many stocks are remarkably expensive on traditional measures, and even somewhat lofty on non-traditional measures. But valuation still matters, especially if the market loses its current luster (assuming that is even possible)!

What are qualified dividends? It’s important to know what makes a dividend qualified for tax purposes. Here’s what you need to know.

A year ago, I unveiled my five contrarian stock market predictions for 2016. For fun and to hold myself accountable, let’s see how I did!

As expected, the market lost a little steam during the past few days, with buyers showing little interest after stocks ramped higher in previous weeks. Of course, the sellers aren’t showing much muscle, either, resulting in a short-term rotational, choppy environment. What about the long-term? Could the rally have already run its course? Sure, it’s always possible, especially given the stop-start environment since early 2011. But the evidence points to an intermediate-term (and longer-term) uptrend in the indexes and most stocks, so you should remain bullish. That doesn’t mean you can’t book a few partial profits on the way up, but you should also hold on to most of your best performers.

This week’s list has some different names, including a few that have recently strengthened after many months of idling. Our favorite of the week is Jazz Pharmaceuticals (JAZZ), a former small-cap leader of 2010 and 2011 that consolidated for the better part of a year before breaking out last week.

Stock Name	Price	Buy Range	Loss Limit
Computer Sciences (CSC)	0.00	31.5-33	-
Concur Technologies (CNQR)	0.00	72-74.5	-
Google Inc. (GOOG)	0.00	710-730	-
HCA Healthcare (HCA)	137.60	31-32	-
Jazz Pharmaceuticals (JAZZ)	0.00	54-58	-
Mellanox Technologies (MLNX)	92.00	104-108	-
MCO (MCO)	0.00	44-45	-
Phillips 66 (PSX)	0.00	45-47	-
Barrick Gold (GOLD)	27.20	114-119	-
Royal Gold, Inc. (RGLD)	129.66	90-95	-

Hindenburg Research released a short report on Roblox (RBLX) stock that, while certainly well-researched, fails to see the forest for the trees.